Structure-Based Design of Non-Natural Macrocyclic Peptides that Inhibit Protein-Protein Interactions

Dennis M Krüger, Adrian Glas, David Bier, Nicole Pospiech, Kerstin Wallraven, Laura Dietrich, Christian Ottmann, Oliver Koch, Sven Hennig, Tom N Grossmann

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Macrocyclic peptides can interfere with challenging biomolecular targets including protein‒protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents which usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide (22) involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts.

Original languageEnglish
Pages (from-to)8982-8988
Number of pages7
JournalJournal of Medicinal Chemistry
Volume60
Issue number21
Early online date13 Oct 2017
DOIs
Publication statusPublished - 13 Oct 2017

Funding

We are grateful for support from AstraZeneca, Bayer CropScience, Bayer HealthCare, Boehringer Ingelheim, Merck KGaA, and the Max-Planck-Society. O.K. is funded by the German Federal Ministry for Education and Research (Medizinische Chemie in Dortmund, Grant No. BMBF 1316053). T.N.G. thanks the Deutsche Forschungsgemein-schaft (DFG; Emmy Noether program GR3592/2-1) and the European Reasearch Council (ERC; ERC starting grant, no. 678623). This work was supported by the Collaborative Research Centre 1093, funded by the Deutsche Forschungsge-meinschaft (DFG). We appreciate IT support by C. Schwittek (MPI Dortmund).

FundersFunder number
Max-Planck-Society
Medizinische Chemie in DortmundBMBF 1316053
AstraZeneca
Boehringer Ingelheim
Bayer CropScience
Merck KGaA
Horizon 2020 Framework Programme678623
European Research Council
Bayer HealthCare
Deutsche ForschungsgemeinschaftGR3592/2-1
Bundesministerium für Bildung und Forschung

    Keywords

    • Journal Article

    Fingerprint

    Dive into the research topics of 'Structure-Based Design of Non-Natural Macrocyclic Peptides that Inhibit Protein-Protein Interactions'. Together they form a unique fingerprint.

    Cite this